Fate Therapeutics Inc Investor Relations Material
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Latest company events
More about Fate Therapeutics Inc
Ticker symbol
FATE
Country
United States of America
About the company
Investor Relations Page
Dig deeper into the Fate Therapeutics Inc fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
